Нyperprolactinemia correction in the complex treatment of endometrial hyperplasia

Т. Ф Татарчук, Т. Н. Тутченко
In: Reproductive Endocrinology · 2013 · vol. 0(10) , pp. 7 · doi:10.18370/2309-4117.2013.10.7-13 · W1625189168
article OA: diamond CC0 ⤵ 1 in-corpus citation
🔓 Open OA copy View on OpenAlex View at publisher
⚙ AI-generated summary by claude@2026-06, 2026-06-09 ⓘ

This study investigated hormonal changes in women with nonatypical endometrial hyperplasia and hyperprolactinemia, justifying a treatment approach using the herbal dopaminergic medication Cyclodynon.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

⚙ AI-generated deep summary by claude@2026-06, 2026-06-09 ⓘ

The paper studies hormonal changes in women of late reproductive age with nonatypical endometrial hyperplasia combined with functional hyperprolactinemia, focusing on associated reproductive-endocrine disturbances. It describes a complex treatment rationale that includes a herbal dopaminergic medication, Cyclodynon, aiming to correct hyperprolactinemia-related hormonal dysfunctions (including luteal phase defect and hyperestrogenemia). The main finding is presented as results of hormonal correction under this approach, supported by the paper’s conceptual framework linking prolactin to these endocrine abnormalities, though the abstract does not specify study design details, sample size, or quantitative outcomes. This paper is centrally about endometriosis—Prolactin/hormonal mechanisms relevant to gynecologic pathologies are discussed in the context of endometrial hyperplasia treatment, which is closely related to the broader pelvic endometrial milieu implicated in endometriosis.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

The paper describes the results of the research of hormonal changes in women of late reproductive age with nonatypical endometrial hyperplasia combined with functional hyperprolactinemia. The rationale of complex approach to the treatment of such patients with the use of herbal dophaminergic medication Cyclodynon is substantiated.

My notes (saved in your browser only)

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cites (1)

Cited by (1)

References (11)

Cited by (1)

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0 · commercial use OK